Drug
Fruquintinib IN Combination With Sintilimab
Fruquintinib IN Combination With Sintilimab: highest development phase Phase 1/2, developed by Hutchmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Hutchmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fruquintinib in Combination with Sintilimab NCT03903705 | Phase 1/2 | Advanced Solid Tumor |
Latest
No recent events.
Follow Fruquintinib IN Combination With Sintilimab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.